Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Current Topics in Medicinal Chemistry|September 18, 2012
Genetic polymorphisms of drug metabolizing enzymes and transporters: the long way from bench to bedsideAlexandre Evrard, Litaty MbatchiBulletin Du Cancer|March 25, 2023
[Unusual association of BRAF and MEK inhibitors: Clinical response of metastatic melanoma treated with dabrafenib-cobimetinib]Fanny Leenhardt, Litaty Mbatchi, Alexandre Evrard, et al.International Journal of Molecular Sciences|March 29, 2023
Combining Three Tyrosine Kinase Inhibitors: Drug Monitoring Is the KeyQuentin Dominique Thomas, Nelly Firmin, Litaty Mbatchi, et al.Pharmacogenomics|January 23, 2020
Pharmacogenetics and pharmacokinetics modeling of unexpected and extremely severe toxicities after sorafenib intakeHai le Ba, Litaty Mbatchi, Florence Gattacceca, et al.Antimicrobial Agents and Chemotherapy|April 13, 2021
Prospective Cohort Study of Micafungin Population Pharmacokinetic Analysis in Plasma and Peritoneal Fluid in Septic Patients with Intra-abdominal InfectionsNicolas Garbez, Litaty Mbatchi, Steven C Wallis, et al.Journal of Pharmaceutical and Biomedical Analysis|July 6, 2020
Liquid chromatography-tandem mass spectrometric assay for the quantification of CDK4/6 inhibitors in human plasma in a clinical context of drug-drug interactionFanny Leenhardt, Matthieu Gracia, Catherine Perrin, et al.European Journal of Medicinal Chemistry|July 12, 2011
Targeting the human malaria parasite Plasmodium falciparum: in vitro identification of a new antiplasmodial hit in 4-phenoxy-2-trichloromethylquinazoline seriesCaroline Castera-Ducros, Nadine Azas, Pierre Verhaeghe, et al.European Journal of Medicinal Chemistry|May 22, 2012
Discovery of a new antileishmanial hit in 8-nitroquinoline seriesLucie Paloque, Pierre Verhaeghe, Magali Casanova, et al.Pharmaceutics|April 23, 2022
Pharmacokinetic Variability Drives Palbociclib-Induced Neutropenia in Metastatic Breast Cancer Patients: Drug-Drug Interactions Are the Usual SuspectsFanny Leenhardt, Frédéric Fiteni, Ludovic Gauthier, et al.Plos One|May 9, 2017
New advances in DPYD genotype and risk of severe toxicity under capecitabineMarie-Christine Etienne-Grimaldi, Jean-Christophe Boyer, Christophe Beroud, et al.Pageof 1